For example, a recent study described a significant correlation between low expression of FOXO3 and a poor prognosis for gastric cancer patients, bringing evidence that FOXO3 could be a valuable prognostic biomarker for patients with gastric cancer98. This evidence concerns the gene FOXO3 and gastric cancer.